Mahanine

Modify Date: 2024-01-03 19:22:33

Mahanine Structure
Mahanine structure
Common Name Mahanine
CAS Number 28360-49-8 Molecular Weight 347.45000
Density N/A Boiling Point N/A
Molecular Formula C23H25NO2 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Mahanine


Mahanine is a carbazole alkaloid with various biological properties. Mahanine is a potent anticancer agent against different types of cancer cells. Mahanine exhibits antileishmanial activity and can be used for Leishmania infection treatment research[1].

 Names

Name mahanine

 Mahanine Biological Activity

Description Mahanine is a carbazole alkaloid with various biological properties. Mahanine is a potent anticancer agent against different types of cancer cells. Mahanine exhibits antileishmanial activity and can be used for Leishmania infection treatment research[1].
Related Catalog
In Vitro Mahanine (0-50 µM; 24 or 48 hours) induces a dose-dependent decrease in cell viability of AG83 promastigotes after 24 hr and 48 hr; the IC50 values were 16.7±1.7 µM and 11.5±0.8 µM respectively. In a drug resistant GE1 strain, Mahanine treatment exhibits dose-dependent cell death in 24 and 48 hr treatment with IC50 values 40.3±2.2 µM and 29.1±1.3 µM respectively[1]. Mahanine (5.0 and 10 µM; 24 hours) exhibits increased accumulation of cells at G2/M phase being 39.0±1.90% and 41.0±2.10% respectively compared to untreated promastigotes (35.3 ± 2.60%) in AG83 promastigote [1]. Mahanine (25 µM; 24 hours) exhibitssignificantly increased intracellular ROS level within 20 min (MFI being 889 ± 26) which reached to 1288 ± 56 after one hour compared to the basal level (604 ± 34) in untreated promastigote. H2DCFDA positivity was measured by FACS[1].
In Vivo Mahanine (oral gavage; 20 mg/kg/40 mg/kg; b.w/day; 5 days) results in 89.1±4.1% reductions in parasite burden at 20 mg/kg, and leads to 96.2±0.3% reductions in parasite burden at 40 mg/kg in a well-established acute model to control Leishmania infection[1]. Animal Model: Balb/c mice with virulent AG83 promastigotes[1] Dosage: 20 mg/kg-40 mg/kg Administration: oral gavage; 20 mg/kg/40 mg/kg; b.w/day; 5 days Result: Had the potential to clear parasite burden in vivo. Exhibited almost complete reduction of parasite burden, upregulation of NO/iNOS/ROS/IL-12 and T cell proliferation in vivo.
References

[1]. Kaushik Bhattacharya, et al. Apoptotic effects of mahanine on human leukemic cells are mediated through crosstalk between Apo-1/Fas signaling and the Bid protein and via mitochondrial pathways. Biochem Pharmacol. 2010 Feb 1;79(3):361-72.

[2]. Saptarshi Roy, et al. Mahanine exerts in vitro and in vivo antileishmanial activity by modulation of redox homeostasis. Sci Rep

 Chemical & Physical Properties

Molecular Formula C23H25NO2
Molecular Weight 347.45000
Exact Mass 347.18900
PSA 45.25000
LogP 6.24580

 Safety Information

Hazard Codes Xi
Top Suppliers:I want be here



Get all suppliers and price by the below link:

Mahanine suppliers

Mahanine price